healthy humans, 1% to 5% of αβ T-cell receptor–positive (TCR+) T cells are CD4−
CD8−(double-negative [DN]) T cells, capable of down-regulating immune responses.
However, the origin and developmental pathway of DN T cells is still not clear. In this study,
by monitoring CD4 expression during T-cell proliferation and differentiation, we identified a
new differentiation pathway for the conversion of CD4+ T cells to DN regulatory T cells. We …